Healthcare Professionals

  • New test panels recommend doses for pain, psychiatric medications

    Cincinnati Children’s Genetic Pharmacology Services now offers expanded pharmacogenetic tests for drugs significantly metabolized by CYP2D6 and CYP2C19 with a fast turnaround time of 48 hours

    These tests identify 21 clinically relevant variants (including deletion and duplications) in CYP2D6 and 8 clinically relevant variants in CYP2C19 and provide more accurate classification of a patient’s ability to metabolize specific medications than does previous genetic pharmacology testing. Better classification leads to more accurate dosing recommendations, thereby improving clinical outcome and reducing risks of adverse side effects.

    • Psychiatry Pharmacogenetics Expanded Panel includes dosing recommendations for 19 commonly prescribed psychiatry medications.
    • Opioid CYP2D6 Pharmacogenetics Panel includes dosing recommendations for four commonly prescribed opioids.

    Testing is appropriate for any patient that may be new to one of these medications, has a lack of therapeutic effect or has difficulties with side effects from any of the medications metabolized by CYP2C19 or CYP2D6. 

    Get additional information, including a list of medications included on each panel. 

 
  • Subscribe Now

    Register today for Pediatric Insights, our monthly e-newsletter for physicians. Receive the latest information on clinical advancements, research updates and news from Cincinnati Children's.

    Subscribe Now >>